BRIEF-Applied Therapeutics Receives Complete Response Letter From U.S. FDA Regarding New Drug Application For Govorestat

Reuters
28 Nov 2024
BRIEF-Applied <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Receives Complete Response Letter From U.S. FDA Regarding New Drug Application For Govorestat

Nov 27 (Reuters) - Applied Therapeutics Inc APLT.O:

  • APPLIED THERAPEUTICS RECEIVES COMPLETE RESPONSE LETTER FROM U.S. FDA REGARDING NEW DRUG APPLICATION FOR GOVORESTAT FOR CLASSIC GALACTOSEMIA

  • APPLIED THERAPEUTICS INC - FDA UNABLE TO APPROVE GOVORESTAT NDA DUE TO CLINICAL DEFICIENCIES

  • APPLIED THERAPEUTICS INC - EXPECTS TO SUBMIT AN NDA EARLY IN Q1 OF 2025

Source text: ID:nGNXZWgTD

Further company coverage: APLT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10